PATENT CLAIM ANALYSIS

Application Number: 16448547
Application Type: Utility
Filing Date: 2019-06
Publication Date: 2019-10
Patent Classification: ["544", "332000"]

Abstract:
The present invention provides compounds of formula I: or a pharmaceutically acceptable salt, tautomer, or stereoisomer thereof, wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds, and methods of using such compounds for treatment of joint damage or joint injury in a mammal, and for inducing differentiation of mesenchymal stem cells into chondrocytes.

Claim (Index 12):
The compound according to  claim 1  or a pharmaceutically acceptable salt, or a stereoisomer thereof, wherein R 3  is selected from wherein \u201c*\u201d represents the point of attachment of R 3  to NH.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 100.0
- Lexical Diversity: 1.4375
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16203122', '14709852', '15587652', '11377886', '15041375']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7942412061742663
- 35 USC 102 Novelty (BERT): 0.5294758548521484
- Combined Prediction Score: 0.7677646710420545
- Mean Citation Score: 308.265822
- Max Citation Score: 348.0071
- Similarity Product: 256.3062006370425

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test